IMMUNEONCO-B (01541) announced that on November 20, 2025, the company notified Huatai Financial to redeem HK$49.6033 million (first redemption) and HK$43.72 million (second redemption) of Huatai redemption products, representing its full holdings at the time. The estimated gains were approximately HK$3.46 million and HK$1.27 million, respectively (collectively referred to as the redemption transactions, reflecting unaudited interest income). Following these redemptions, the group no longer holds any outstanding wealth management products from Huatai Financial. Additionally, on November 20, 2025, the company agreed to subscribe to a HK$120 million wealth management product (Huatai subscription product) from Huatai Financial (the subscription transaction). The subscription was funded by the group's internal surplus cash reserves.
Comments